ClariPulmo_Fully Automated AI Powered 3D Reporting Solution for COVID19
AI-powered solution for low-dose CT screening
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Brand name
- ClariPulmo
- Payment Terms
- T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- ct, ct analyzer, ct scanner, diagnosis medical solutions
South Korea
| Product name | ClariPulmo_Fully Automated AI Powered 3D Reporting Solution for COVID19 | Certification | - |
|---|---|---|---|
| Category |
Monitoring & Diagnostic Equipment
Ultrasound Scanner Other Monitoring & Diagnostic Equipment |
Material | - |
| Keyword | ct , ct analyzer , ct scanner , diagnosis medical solutions | Unit Size | - |
| Brand name | ClariPulmo | Unit Weigh | - |
| origin | South Korea | Stock | 1 |
| Supply type | Available | HS code | - |
Product Information
ClariPulmo
- Fully Automated AI-Powered 3D Reporting Solution for Emphysema and Covid-19 Pneumonia
ClariPulmo is an AI-powered tri-functional solution kit best suited for low-dose lung CT screening.
Our powerful pre-trained deep learning model provides accurate quantitative analysis of lung nodules as well as low-attenuation and high-attenuation lesions such as emphysema and pneumonia from low-dose CT images, despite strong image noise and varying scan conditions.
The ClariPulmo in conjunction with the ClariCT.AI can help achieve the best practice in lung screening by reducing noise induced bias with this 3D reporting.
How can ClariPulmo help with COVID-19?
- Infection with COVID-19 has symptoms such as high fever, cough and pneumonia
- Early detection of pneumonia is vital because it may initially show mild symptoms similar to cold,
but may rapidly worsen to be deadly
- ClariPulmo can help with early diagnosis by detecting and analyzing areas suspected of COVID-19 pneumonia on CT
Benefits
1) Compliant with DICOM
; Seamless integration with any CT scanner and PACS system
2) Fully Automated
; Several automatic options for measurement, analysis, segmentation and more
3) Enhances image Clarity
; Provides accurate quantitative analysis of lung nodules and low and high attenuation lesions
4) Help Predict the Risth
; Helps predict the risk of developing COPD
B2B Trade
| Price (FOB) | Negotiable | transportation | Negotiation Other |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | T/T | Shipping time | Negotiable |
- President
- Kim Jong hyo
- Address
- (3F) 70-15Ihwajang-gil Jongno-gu South Korea, Jongno-gu, Seoul, Korea
- Product Category
- Other Monitoring & Diagnostic Equipment
- Year Established
- 2015
- Company introduction
-
ClariPi is an AI company that offers innovative medical imaging solutions through deep-learning and AI technology to change the standards of patient safety, making it our number one priority to reduce harmful health risks. Our products help patients get CT scans with radiation dose at virtually harmless level (1/10th of current practice) and yet produces high-quality images for diagnosis.
[Our Key Products]
* ClariCT.AI: provides powerful denoising and image clarity enabled by our signature AI-powered clarity engine. This product is to be paired with low-dose and ultra-low-dose CT scans to ensure the protection of patients and staff.
* ClariPulmo: a fully automated AI-powered 3D reporting solution for emphysema and COVID-19 pneumonia. Our powerful pre-trained deep learning model provides accurate quantitative analysis of lung nodules as well as low-attenuation and high-attenuation lesions despite strong image noise and varying scanning conditions. It is best suited for low-dose lung CT screenings. Ask us how this product can help with COVID-19.
* ClariSIGMAM: a fully automated zero-click breast density assessment solution that provides accurate and consistent density estimates from standard digital mammograms.
* ClariOsteo: an AI-powered precision bone healthcare solution with low-dose CT images. It uses existing CT scans and automatically provides analysis reports on spine fractures and osteoporosis risks which is useful for prevention and treatment management.
* ClariACE: an AI-powered augmented contrast enhancing solution for low-dose CECT images. Our powerful pre-trained deep learning model selectively boosts contrast agent components in CT images without increasing contrast agent doses for patients. It clearly and selectively enhances the contrast of iodine without increasing noise in CT images.
Our representative can give you a quick demo of these products as well as detailed image comparisons if you are interested. If you have any question, please message me or visit our website at www.claripi.com.
- Main Product
